WPHM — Winston Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Winston Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 September 30th | 2007 September 30th | 2008 December 31st | 2009 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0.453 | 1.39 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 0.425 | 0.215 | 5.69 | 4.14 |
| Operating Profit | -0.425 | -0.215 | -5.23 | -2.74 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.464 | -0.18 | -5.14 | -2.66 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.464 | -0.18 | -5.14 | -2.66 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.464 | -0.18 | -5.14 | -2.66 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -0.464 | -0.18 | -5.14 | -2.66 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.764 | -0.109 | -0.096 | -0.043 |
| Dividends per Share |